IBDEI1GH ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23546,0)
 ;;=Z79.51^^78^1016^9
 ;;^UTILITY(U,$J,358.3,23546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23546,1,3,0)
 ;;=3^Long Term Current Use of Inhaled Steroids
 ;;^UTILITY(U,$J,358.3,23546,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,23546,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,23547,0)
 ;;=Z79.52^^78^1016^11
 ;;^UTILITY(U,$J,358.3,23547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23547,1,3,0)
 ;;=3^Long Term Current Use of Systemic Steroids
 ;;^UTILITY(U,$J,358.3,23547,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,23547,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,23548,0)
 ;;=Z91.19^^78^1016^12
 ;;^UTILITY(U,$J,358.3,23548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23548,1,3,0)
 ;;=3^Non-Compliance w/ Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,23548,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,23548,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,23549,0)
 ;;=Z87.01^^78^1016^15
 ;;^UTILITY(U,$J,358.3,23549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23549,1,3,0)
 ;;=3^Personal Hx of Pneumonia,Recurrent
 ;;^UTILITY(U,$J,358.3,23549,1,4,0)
 ;;=4^Z87.01
 ;;^UTILITY(U,$J,358.3,23549,2)
 ;;=^5063480
 ;;^UTILITY(U,$J,358.3,23550,0)
 ;;=Z92.22^^78^1016^13
 ;;^UTILITY(U,$J,358.3,23550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23550,1,3,0)
 ;;=3^Personal Hx of Monoclonal Drug Therapy
 ;;^UTILITY(U,$J,358.3,23550,1,4,0)
 ;;=4^Z92.22
 ;;^UTILITY(U,$J,358.3,23550,2)
 ;;=^5063631
 ;;^UTILITY(U,$J,358.3,23551,0)
 ;;=Z33.1^^78^1016^16
 ;;^UTILITY(U,$J,358.3,23551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23551,1,3,0)
 ;;=3^Pregnancy,Incidental to
 ;;^UTILITY(U,$J,358.3,23551,1,4,0)
 ;;=4^Z33.1
 ;;^UTILITY(U,$J,358.3,23551,2)
 ;;=^5062853
 ;;^UTILITY(U,$J,358.3,23552,0)
 ;;=Z13.83^^78^1016^18
 ;;^UTILITY(U,$J,358.3,23552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23552,1,3,0)
 ;;=3^Screening for Repiratory Disorder
 ;;^UTILITY(U,$J,358.3,23552,1,4,0)
 ;;=4^Z13.83
 ;;^UTILITY(U,$J,358.3,23552,2)
 ;;=^5062715
 ;;^UTILITY(U,$J,358.3,23553,0)
 ;;=Z13.820^^78^1016^17
 ;;^UTILITY(U,$J,358.3,23553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23553,1,3,0)
 ;;=3^Screening for Osteoporosis
 ;;^UTILITY(U,$J,358.3,23553,1,4,0)
 ;;=4^Z13.820
 ;;^UTILITY(U,$J,358.3,23553,2)
 ;;=^5062713
 ;;^UTILITY(U,$J,358.3,23554,0)
 ;;=Z23.^^78^1016^4
 ;;^UTILITY(U,$J,358.3,23554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23554,1,3,0)
 ;;=3^Immunization Visit
 ;;^UTILITY(U,$J,358.3,23554,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,23554,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,23555,0)
 ;;=Z01.82^^78^1016^1
 ;;^UTILITY(U,$J,358.3,23555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23555,1,3,0)
 ;;=3^Allergy Testing Visit
 ;;^UTILITY(U,$J,358.3,23555,1,4,0)
 ;;=4^Z01.82
 ;;^UTILITY(U,$J,358.3,23555,2)
 ;;=^5062629
 ;;^UTILITY(U,$J,358.3,23556,0)
 ;;=Z01.84^^78^1016^2
 ;;^UTILITY(U,$J,358.3,23556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23556,1,3,0)
 ;;=3^Antibody Response Exam
 ;;^UTILITY(U,$J,358.3,23556,1,4,0)
 ;;=4^Z01.84
 ;;^UTILITY(U,$J,358.3,23556,2)
 ;;=^5062631
 ;;^UTILITY(U,$J,358.3,23557,0)
 ;;=Z82.5^^78^1016^3
 ;;^UTILITY(U,$J,358.3,23557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23557,1,3,0)
 ;;=3^Family Hx of Asthma
 ;;^UTILITY(U,$J,358.3,23557,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,23557,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,23558,0)
 ;;=Z87.891^^78^1016^14
 ;;^UTILITY(U,$J,358.3,23558,1,0)
 ;;=^358.31IA^4^2
